Clinical Trial Update: Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated the safety of administering Trogarzo (ibalizumab) undiluted via IV push or by intramuscular injection in HIV-1 infection. The trial ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Trogarzo (ibalizumab)

Snippet

Sponsor: TaiMed Biologics Inc. | Conditions: HIV-1-infection | Phase 3 | Status: COMPLETED | Results posted: 2025-10-20